Dose heterogeneity in the target volume and intensity-modulated radiotherapy to escalate the dose in the treatment of non-small-cell lung cancer.

[1]  Joos V Lebesque,et al.  Regional differences in lung radiosensitivity after radiotherapy for non-small-cell lung cancer. , 2004, International journal of radiation oncology, biology, physics.

[2]  M. Fippel.  Efficient particle transport simulation through beam modulating devices for Monte Carlo treatment planning. , 2004, Medical physics.

[3]  Issam El-Naqa,et al.  Dosimetric correlates for acute esophagitis in patients treated with radiotherapy for lung carcinoma. , 2004, International journal of radiation oncology, biology, physics.

[4]  Radhe Mohan,et al.  Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small-cell lung cancer. , 2004, International journal of radiation oncology, biology, physics.

[5]  Thomas Guerrero,et al.  Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer. , 2004, International journal of radiation oncology, biology, physics.

[6]  Di Yan,et al.  Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation. , 2003, International journal of radiation oncology, biology, physics.

[7]  Joos V Lebesque,et al.  Incorporating an improved dose-calculation algorithm in conformal radiotherapy of lung cancer: re-evaluation of dose in normal lung tissue. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[8]  L. Boersma,et al.  First results of a phase I/II dose escalation trial in non-small cell lung cancer using three-dimensional conformal radiotherapy. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[9]  M. V. van Herk,et al.  Precise and real-time measurement of 3D tumor motion in lung due to breathing and heartbeat, measured during radiotherapy. , 2002, International journal of radiation oncology, biology, physics.

[10]  Kurt Baier,et al.  Dose, volume, and tumor control prediction in primary radiotherapy of non-small-cell lung cancer. , 2002, International journal of radiation oncology, biology, physics.

[11]  Y. Seppenwoolde.  Radiation induced lung damage , 2002 .

[12]  M van Herk,et al.  Field size reduction enables iso-NTCP escalation of tumor control probability for irradiation of lung tumors. , 2001, International journal of radiation oncology, biology, physics.

[13]  M. Alber,et al.  Optimization of intensity modulated radiotherapy under constraints for static and dynamic MLC delivery. , 2001, Physics in medicine and biology.

[14]  F Nüsslin,et al.  A variable fluence step clustering and segmentation algorithm for step and shoot IMRT. , 2001, Physics in medicine and biology.

[15]  T Pawlicki,et al.  Monte Carlo simulation for MLC-based intensity-modulated radiotherapy. , 2001, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

[16]  R Mohan,et al.  Monte Carlo dose calculations for dynamic IMRT treatments. , 2001, Physics in medicine and biology.

[17]  M. Alber,et al.  Monte Carlo dose computation for IMRT optimization. , 2000, Physics in medicine and biology.

[18]  H Shirato,et al.  Impact of respiratory movement on the computed tomographic images of small lung tumors in three-dimensional (3D) radiotherapy. , 2000, International journal of radiation oncology, biology, physics.

[19]  Fridtjof Nüsslin,et al.  Hyperion — An integrated IMRT planning tool , 2000 .

[20]  R. Jeraj,et al.  Monte Carlo-based inverse treatment planning. , 1999, Physics in medicine and biology.

[21]  R K Ten Haken,et al.  Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients. , 1999, Lung cancer.

[22]  M. Alber,et al.  An objective function for radiation treatment optimization based on local biological measures. , 1999, Physics in medicine and biology.

[23]  A Ottolenghi,et al.  Long-term cardiac mortality after radiotherapy of breast cancer--application of the relative seriality model. , 1996, The British journal of radiology.

[24]  R Mohan,et al.  Clinically relevant optimization of 3-D conformal treatments. , 1992, Medical physics.

[25]  J. Lebesque,et al.  The simultaneous boost technique: the concept of relative normalized total dose. , 1991, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[26]  J. Fowler.  Radiation-induced lung damage: dose-time fractionation considerations. , 1990, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[27]  C. Burman,et al.  Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method. , 1989, International journal of radiation oncology, biology, physics.

[28]  H. Withers,et al.  Alpha/beta value and the importance of size of dose per fraction for late complications in the supraglottic larynx. , 1986, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.